Login

Financial Snapshot

Revenue
TTM
$1.559B
Gross Margin
TTM
61.77%
Net Income
TTM
$76.30M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
267.52%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$788.9M
Cash
2026 Q2
P/E
TTM
122.7
Free Cash Flow
TTM
$207.1M

Stock Price

Loading...
Market Cap: $9.362 Billion

About Masimo Corp

Masimo Corp (NASDAQ: MASI) is a medical technology company that develops and manufactures noninvasive patient monitoring systems, sensors, and connectivity platforms for clinical settings. Revenue comes from selling proprietary monitoring hardware, single-patient-use sensors, and connectivity software to hospitals and healthcare facilities. Core products include Masimo SET pulse oximetry, rainbow Pulse CO-Oximetry, the Root patient monitoring and connectivity platform, and the Patient SafetyNet Series 5000. The company also licenses its signal-processing technology to more than 90 OEM partners, who integrate Masimo circuit boards into their own multi-parameter monitors. End markets span high-acuity ICUs, surgical suites, operating rooms, general care floors, recovery units, and long-term care facilities. The OEM channel extends Masimo technology into over 200 third-party monitors. Switching costs are embedded in the sensor-to-monitor architecture, where proprietary single-use sensors are consumed continuously at each installed monitor. Founded in 1989 and headquartered in Irvine, California, Masimo files under a December fiscal year-end.

Revenue model
Hardware sales of bedside monitors and handheld devices, recurring revenue from single-patient-use sensors tied to installed monitors, OEM licensing of circuit boards and signal-processing modules to third-party monitor manufacturers, and software and connectivity platform sales including Root, UniView, and Patient SafetyNet Series 5000.
Products and services
Masimo SET pulse oximetry monitors and sensors; rainbow Pulse CO-Oximetry platform measuring SpO2, SpCO, SpMet, SpHb, SpfO2, PVi, RPVi, RRp, and SpOC; Root patient monitoring and connectivity hub; Patient SafetyNet Series 5000; Rad-97 bedside monitor; Rad-G handheld spot-check pulse oximeter; Iris Gateway; Kite; iSirona; UniView and UniView 60; MyView; Hospital Automation Connectivity; MX-7 and MSX-2040 OEM circuit boards; uSpO2 board-in-cable solution; rainbow Acoustic Monitoring (RRa).
Customers and end markets
Hospitals including ICUs, surgical suites, operating rooms, general care floors, recovery units, and long-term care facilities. OEM partners (more than 90 as disclosed in the 10-K filed 2026-02-27) integrate Masimo technology into their own multi-parameter monitors.
Value-chain role
Medical device original equipment manufacturer and technology licensor. Masimo develops proprietary signal-extraction algorithms, manufactures finished monitoring devices and sensors for direct hospital sale, and supplies OEM circuit boards and modules to third-party monitor makers. Also operates as a connectivity middleware provider linking bedside devices to EMR systems.

Source: SEC 10-K, filed 2026-02-27

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Abbott Laboratories ABIOMED INC Envista Holdings Corp Globus Medical Inc HOLOGIC INC Inspire Medical Systems Inc Insulet Corp Penumbra Inc Shockwave Medical, Inc. Teleflex Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support